Patients with Hepatic Impairment The pharmacokinetics of nirmatrelvir were similar in patients with moderate (Child-Pugh Class B) hepatic impairment compared to healthy subjects following administration of a single oral dose of nirmatrelvir 100 mg (0.33 times the approved recommended dose) co-administered with ritonavir 100 mg
Tirzepatide is an excellent option for individuals who: Have type 2 diabetes or prediabetes Struggle with obesity or excess weight Have high blood pressure or high cholesterol Have a family history of heart disease Want to proactively improve their heart health Is Tirzepatide Right for You
Two recent trials evaluated different maintenance-phase options after achieving significant weight loss on GLP-1 injections
While the exact mechanisms are still being studied, the primary goal of our GLP-1 injections is to assist individuals in managing their weight by addressing factors like hunger and metabolism
This non-surgical solution is perfect for clients seeking a slimmer, more contoured appearance in areas resistant to diet and exercise
Also, because Ozempic is not indicated for weight management, research on its effectiveness solely for weight loss is limited